ImmunOs Therapeutics AG
ImmunOs Therapeutics AG is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series C+, 3 tracked investors.
About ImmunOs Therapeutics AG
ImmunOs Therapeutics AG is a company founded in 2019 headquartered in Switzerland. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
ImmunOs Therapeutics AG is a biotechnology company that develops HLA-based immunotherapies and human immunomodulatory proteins for cancer and autoimmune diseases. The company uses an HLA-driven platform to generate biologic therapeutics intended to engage innate and adaptive immunity and remodel the tumor microenvironment.
Explore ImmunOs Therapeutics AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.